Company / Capital Returned to Shareholders per Share
Viatris Capital Returned to Shareholders per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.41
FY2025
5-year range
$0.21 / $0.41
FY2021-FY2025
Trend
+101.9%
vs FY2024
Sector context
#34 of 51
Health Care
What the data says
At $0.41, Viatris's capital returned to shareholders per share ranks #34 of 51 in the Health Care sector. Capital Returned to Shareholders per Share returned to growth in FY2025 after 2 years of decline, reaching $0.41.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of -13.1%.
Improved from $0.21 to $0.41 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -13.1%
- 10-Year CAGR
- -
Sector benchmark
-84.8% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 101.9% year-over-year.
- Ranks #34 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2020.
- Lowest capital returned to shareholders per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +101.9% |
| FY2024 | $0.21 | -0.7% |
| FY2023 | $0.21 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.84 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.84 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026